Shingles vaccine linked to 24% lower dementia risk
A study found that older adults receiving the shingles vaccine had a 24% lower risk of dementia over four years compared to unvaccinated peers. Analyzing Medicare data from over 500,000 adults aged 66 and older, researchers noted the vaccine's neuroprotective benefits. The findings, published in Annals of Internal Medicine, suggest a significant link between shingles vaccination and reduced dementia risk.